Cargando…
Identifying High-Risk NASH Patients: What We Know so Far
Steatosis is a condition of hepatic fat overload that is associated with overweight and the metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease with a global impact on healthcare. A proportion of NAFLD patients develops nonalcoholic steatohepatitis (...
Autores principales: | Schulz, Marten, Tacke, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493213/ https://www.ncbi.nlm.nih.gov/pubmed/32982495 http://dx.doi.org/10.2147/HMER.S265473 |
Ejemplares similares
-
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
What we know so far
Publicado: (2021) -
Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021)